EFTA01388661.pdf

Emerging player in the minimally invasive outpatient pain Differentiated market, focusing on the relatively infant "Midline" Spine Surgery sector Approved Commercial Riding industry tailwinds of aging demographics, transition to Reimbursed outpatient care settings, and strong focus on faster recovery Derisked and risk-reduction Proposed raise: $20-25mm Strong track record with support from the LINK Group in terms of industry and technological expertise, intellectual and financial capital, commercial experience, and etc. Investment proceeds will be used to: • Build a robust commercial sales and marketing infrastructure Deutsche Bank key contacts: ▪ Expand geographically, specifically in the sun-belt states of Florida, Georgia, Texas, Arizona and California Seth Damergy Benjamin Bible ▪ Hybrid distribution strategy to include direct representation and Managing Director Vice President partnership with independent agents that focus upon novelty Global Head of Medical Technology Healthcare, Medical Technology ▪ Launch, commercialize, and tightly integrate unique and low-cost navigation system for maximized pull through of implant platform • Continue to innovate highly-engineered novelty minimally-invasive products LINKSPINE 8 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0092346 CONFIDENTIAL SDNY_GM_00238530 EFTA01388661